Search alternatives:
significantly less » significantly lower (Expand Search), significantly reduce (Expand Search), significantly better (Expand Search)
better decrease » greater decrease (Expand Search), between decreased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
less decrease » mean decrease (Expand Search), we decrease (Expand Search), levels decreased (Expand Search)
significantly less » significantly lower (Expand Search), significantly reduce (Expand Search), significantly better (Expand Search)
better decrease » greater decrease (Expand Search), between decreased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
less decrease » mean decrease (Expand Search), we decrease (Expand Search), levels decreased (Expand Search)
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
Key Resources.
Published 2025“…Unexpectedly, we found that Tax1bp1-deficient mice were less susceptible to <i>Mtb</i> infection, and generated reduced inflammatory cytokine responses, compared to wild-type mice; the same mutant mice exhibited decreased growth of, and inflammatory cytokine responses to, <i>Listeria monocytogenes</i>, suggesting that Tax1bp1 plays a role in host responses to multiple intracellular pathogens. …”
-
92
Tax1bp1-deficiency reduces autophagy flux.
Published 2025“…Unexpectedly, we found that Tax1bp1-deficient mice were less susceptible to <i>Mtb</i> infection, and generated reduced inflammatory cytokine responses, compared to wild-type mice; the same mutant mice exhibited decreased growth of, and inflammatory cytokine responses to, <i>Listeria monocytogenes</i>, suggesting that Tax1bp1 plays a role in host responses to multiple intracellular pathogens. …”
-
93
-
94
Study data.
Published 2025“…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”
-
95
Summary of clinical outcomes after 9 months.
Published 2025“…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”
-
96
Approval by the research ethics committee.
Published 2025“…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”
-
97
-
98
-
99
-
100